SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
North Haven Private Income Fund LLC completed an unregistered sale of approximately 317,050 Class S units for $5.67 million to accredited investors pursuant to subscription agreements, exempt under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →Bain Capital Private Credit sold 389,036 unregistered Class I common shares to feeder vehicles for approximately $10.1 million, relying on Section 4(a)(2) and Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →North Haven Private Income Fund A LLC completed an unregistered sale of approximately 21,465 Class I units for $0.4 million, relying on Section 4(a)(2) and Regulation D exemptions with accredited investor representations.
View raw filing on EDGAR →LGAM Private Credit LLC sold approximately 177,957 Common Units for $3.5 million at $19.53 per unit pursuant to subscription agreements, relying on Regulation S and other exemptions from Securities Act registration.
View raw filing on EDGAR →Apollo Infrastructure Co LLC completed an unregistered private placement of approximately $40.6 million in equity securities across multiple share classes (Series I and Series II A-II, F-I, and I Shares) to accredited and non-U.S. investors under Section 4(a)(2), Regulation D, and Regulation S.
View raw filing on EDGAR →B&R Technology Merger Corp. partially exercised its IPO over-allotment option, issuing 3,500,000 additional units at $10.00 per unit for $35,000,000 in gross proceeds, plus concurrent private placement units to the Sponsor. The issuance of Class A ordinary shares and warrants materially dilutes existing shareholders.
View raw filing on EDGAR →PennantPark Private Income Fund issued 137,883 common shares for approximately $3.57 million in an unregistered private offering relying on Section 4(a)(2) and Regulation D exemptions, diluting existing shareholders' ownership.
View raw filing on EDGAR →Apollo Asset Backed Credit Co LLC completed unregistered sales of equity securities totaling approximately $32.9 million across Series I and Series II share classes to third-party investors as of August 1, 2026, pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions.
View raw filing on EDGAR →Grown Rogue issued unregistered equity securities to a capital partner in connection with the PharmaCann acquisition financing, including 300,000 subordinate voting shares as a commitment fee, warrants exercisable at $0.55, and up to 18.2 million shares upon conversion of a $10 million preferred equity interest at escalating prices ($0.55–$0.76), representing approximately 7% dilution at current prices with total potential dilution material to shareholders.
View raw filing on EDGAR →Caring Brands entered into a Securities Purchase Agreement on August 21, 2026, to issue up to 11,000 shares of Series B Convertible Preferred Stock and 22,000,000 warrants in a private placement for $11 million in gross proceeds under Section 4(a)(2) and Regulation D. The transaction carries significant dilution potential with aggregate shares issuable capped at 19.99% of outstanding common stock, requiring stockholder approval to exceed this threshold.
View raw filing on EDGAR →Madison Air Solutions entered into Securities Purchase Agreements to sell 90,108,130 shares of Class A common stock at $24.97 per share in a private placement generating approximately $2.25 billion in gross proceeds to accredited investors, including the controlling shareholder. The unregistered shares are issued under Section 4(a)(2) exemption and will materially dilute existing shareholders' ownership percentages and earnings per share, serving as key financing for the company's acquisition of ebm-papst entities.
View raw filing on EDGAR →NuRAN Wireless has filed a final short-form base shelf prospectus and received final regulatory approval to offer securities (common shares, debt, or other instruments) to the public, strategic investors, or through at-the-market distributions. The company explicitly states it intends to use proceeds to fund infrastructure expansion and working capital. While no specific offering has been launched yet, the shelf prospectus establishes the legal framework for future dilutive equity issuances and represents a material capital-raising event that would affect investor assessment of future ownership dilution and the company's financing strategy.
View raw filing on EDGAR →TPG Private Equity Opportunities, L.P. sold $82.6 million of unregistered limited partnership units on August 1, 2026, across multiple classes (Class I, S, and F) to third-party investors and affiliates under Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →Agnico Eagle announced a non-brokered private placement investment in Radisson Mining Resources Inc., acquiring 53,420,000 units (comprising common shares and warrants) for C$57.2 million. While this is technically an investment by Agnico Eagle in another company (Radisson), the structure involves Agnico Eagle acquiring newly-issued equity securities of Radisson in a private placement, which is dilutive to existing Radisson shareholders. The transaction is material given the size (C$57.2M) and strategic nature, and Agnico Eagle will hold ~10.45% of Radisson on a non-diluted basis and ~14.90% on a partially-diluted basis, with investor rights including board nomination and participation rights.
View raw filing on EDGAR →Nebius Group announced the closing of a $5.75 billion private offering of convertible senior notes (0.50% due 2030 and 4.50% due 2034) to qualified institutional buyers under Rule 144A. The offering includes convertible securities that are dilutive upon conversion, and the company concurrently exchanged $800 million of existing convertible notes for approximately 15.8 million Class A ordinary shares. This is a material capital-raising transaction involving dilutive securities that would significantly affect investor assessment of share dilution and capital structure.
View raw filing on EDGAR →Fortress Private Lending Fund sold 309,338 Class I common shares for $7.5 million in aggregate consideration to accredited investors pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →KLX Energy Services commenced a subscription rights offering on August 24, 2026, allowing eligible holders to purchase common stock at $1.49 per share. This is a dilutive equity issuance to existing shareholders and warrant holders. The company intends to use proceeds for general corporate purposes and to repurchase 2030 Notes, indicating capital-raising activity typical of financially stressed mid-cap issuers. The offering structure—transferable rights, backstop agreement with noteholders, and 9.995% ownership limitations—is characteristic of a dilutive capital raise.
View raw filing on EDGAR →Silver Point Private Credit Fund issued and sold 683,801 unregistered common shares for $18.38 million pursuant to subscription agreements, exempt under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →The filing discloses a public offering of 13,250,000 shares of common stock closed on August 12, 2026, plus the full exercise of an underwriter option for an additional 1,987,500 shares, with forward sale agreements entered into on August 20, 2026. The company intends to deliver these shares upon physical settlement by August 10, 2028, in exchange for cash proceeds to fund a pending acquisition and general corporate purposes. This represents a material dilutive equity issuance that would significantly affect shareholder ownership and the total mix of information available to investors.
View raw filing on EDGAR →The disclosure centers on convertible debentures issued to Yorkville with $25.775 million aggregate principal, of which $5.775 million has been converted and $20.0 million remains outstanding. Convertible debentures are inherently dilutive securities that can result in issuance of common stock upon conversion. The filing emphasizes "future conversions of the Convertible Debentures" and "potential issuance of additional shares of common stock," signaling material dilution risk to existing shareholders. While the Item 7.01 designation and "Regulation FD Disclosure" framing suggest informational rather than transactional disclosure, the substance involves a dilutive financing arrangement material to investor assessment.
View raw filing on EDGAR →The 6-K discloses a private placement of 2,000,000 Class A ordinary shares at $1.00 per share and 50,000 Class B ordinary shares at $2.50 per share, closed on August 18, 2026, generating approximately $2.125 million in gross proceeds. The securities were issued in reliance on Section 4(a)(2) of the Securities Act and Regulation S, with no general solicitation. This is a classic unregistered equity issuance that dilutes existing shareholders and materially affects the capital structure.
View raw filing on EDGAR →StablecoinX entered into Note Consolidation and Restructuring Agreements on August 21, 2026, converting approximately $6.9 million in convertible promissory notes into warrants (Tranche A and Tranche B) exercisable for Class A common stock. Item 3.02 explicitly discloses the unregistered issuance of these warrants in reliance on Section 4(a)(2) of the Securities Act. The conversion of debt into equity warrants represents a dilutive issuance material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →The Company suspended and is terminating its at-the-market (ATM) sales agreement with Chaince Securities, LLC under which it had sold 25,606,595 Ordinary Shares for approximately $2.3 million in gross proceeds since July 2026. While the termination itself is administrative, the disclosure documents the completion of a dilutive equity issuance under an ATM offering program, which materially affects shareholder equity and voting power. The suspension and termination of the agreement is the operative event being disclosed.
View raw filing on EDGAR →Change Agents Corporation amended its Equity Purchase Agreement with Hudson Global Ventures, LLC on August 21, 2026, establishing a $10,000,000 equity line of credit whereby the Company can require the Investor to purchase common stock at $0.20 per share, subject to an Exchange Cap limiting issuances to 19.99% of outstanding shares pending stockholder approval. This unregistered equity issuance is material and dilutive to existing shareholders.
View raw filing on EDGAR →Greenland Mines entered into an at-the-market (ATM) sales agreement with A.G.P./Alliance Global Partners on August 24, 2026, authorizing the sale of up to $50,000,000 in common stock shares. This is a classic dilutive equity issuance under Rule 415(a)(4), where the company may sell registered shares at market prices through a sales agent. The filing explicitly describes this as an "ATM Offering" and notes the company has no obligation to sell but may do so from time to time, making this a material capital-raising activity that would dilute existing shareholders.
View raw filing on EDGAR →The Company entered into two registered direct offerings on August 18 and August 20, 2026, selling 340,000 shares and 451,250 shares of common stock respectively, plus pre-funded warrants to purchase 260,000 and 1,111,250 additional shares, for aggregate gross proceeds of approximately $6.8 million. This is a material dilutive equity issuance that raises capital through the sale of common stock and immediately-exercisable warrants, typical of a PIPE-like registered direct offering structure.
View raw filing on EDGAR →The Company issued 773,361 shares of common stock (220,264 + 553,097) to Lind Global Asset Management in satisfaction of conversion obligations under senior secured convertible promissory notes totaling $9.9 million in principal. The disclosure explicitly states reliance on Section 3(a)(9), Section 4(a)(2), and Rule 506 of Regulation D—all exemptions from registration under the Securities Act—and notes the issuance was to an existing securityholder without general solicitation. This is a classic dilutive equity issuance by a small-cap biotech company to a financial investor, material to shareholders' ownership and voting interests.
View raw filing on EDGAR →The filing discloses two equity issuances: (1) an unregistered sale of 107,920 shares to Yorkville under a Standby Equity Purchase Agreement for $851,194 (Item 3.02), and (2) a registered direct offering of 307,692 shares for approximately $2.0 million (Item 8.01/press release). Both represent dilutive equity issuances to raise capital. Item 3.02 explicitly covers unregistered sales under Section 4(a)(2) and Regulation D, which is the core dilutive_issuance category. The registered offering, while technically registered, is still a material capital raise that dilutes existing shareholders.
View raw filing on EDGAR →Jupiter Neurosciences completed a registered direct offering on August 24, 2026, issuing 307,692 shares of common stock at $6.50 per share for approximately $2.0 million in gross proceeds. The filing explicitly discloses this equity issuance under Item 8.01 and notes the company's reliance on the offering proceeds to maintain compliance with Nasdaq's $2.5 million stockholders' equity listing requirement, indicating material capital-raising activity and dilution to existing shareholders.
View raw filing on EDGAR →Skye Bioscience entered into a Securities Purchase Agreement with Redmile Biopharma Investments III, L.P. on August 21, 2026, to sell up to $22,000,000 of ELOC Shares (common and non-voting convertible shares) plus a warrant to purchase additional shares valued at $5,000,000, pursuant to Section 4(a)(2) exemption. The transaction includes a 19.99% cap on outstanding shares (subject to stockholder approval for excess) and a 9.99% beneficial ownership limitation for the investor, representing significant equity dilution for existing shareholders.
View raw filing on EDGAR →The filing discloses multiple unregistered sales of equity securities by Brookfield Real Estate Income Trust Inc. during August 2026, including 115,918 Class I shares to the Adviser as management fees, 24,886 Class C shares to a feeder vehicle, 6,517 Class I shares via distribution reinvestment to a feeder vehicle, 124,331 Class I shares via distribution reinvestment to Brookfield affiliates, and 26,633 Class E shares to Brookfield employees, totaling approximately $3.3 million in aggregate consideration. These private placements under Section 4(a)(2) and Regulation S/D represent dilutive equity issuances that would materially affect investor assessment of share ownership and capital structure.
View raw filing on EDGAR →Blue Owl Credit Income Corp. completed an unregistered private placement of 251,525 shares of Class I common stock to feeder vehicles for approximately $2.3 million, exempt under Section 4(a)(2) and Regulation S.
View raw filing on EDGAR →Blue Owl Technology Income Corp. completed an unregistered private placement of 136,101 shares of Class I common stock to feeder vehicles for $1,316,100, exempt under Section 4(a)(2) and Regulation S.
View raw filing on EDGAR →The filing discloses an unregistered sale of 272,642 common shares for $7,126,860 pursuant to Section 4(a)(2) and Regulation D/S under the Securities Act. This is a classic dilutive issuance of equity securities outside registered offerings, which materially affects existing shareholders' ownership percentages and is a key disclosure for investors assessing capital structure and dilution risk.
View raw filing on EDGAR →Golub Capital Private Income Fund S issued 2,068 common shares of beneficial interest for $50,000 in consideration pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions, representing an unregistered equity issuance outside registered offerings.
View raw filing on EDGAR →Golub Capital Private Income Fund I issued 53,881 common shares of beneficial interest for $1,305,000 as of August 1, 2026, pursuant to subscription agreements and exempt under Section 4(a)(2), Regulation D, and/or Regulation S.
View raw filing on EDGAR →The Company increased the maximum aggregate offering price under an at-the-market (ATM) sales agreement with Benchmark and StoneX by $2,270,000 in additional common stock, following approximately $2,228,999 already sold under the same agreement. This is a dilutive equity issuance disclosed under Item 8.01, representing a material capital-raising activity that would affect shareholder ownership and the total mix of information available to investors.
View raw filing on EDGAR →Nebius Group announced pricing of a $5.0 billion private offering of convertible senior notes (upsized from $4.5 billion) to qualified institutional buyers under Rule 144A, with settlement expected August 24, 2026. The convertible notes are dilutive securities that will result in issuance of approximately 15.8 million Class A shares through concurrent exchange transactions with existing convertible noteholders, plus additional shares upon conversion of the new notes. This is a material capital-raising event typical of dilutive issuances at growth-stage technology companies.
View raw filing on EDGAR →Stone Point Credit Income Fund issued 113,049.904 common shares at NAV of $24.6493 for an aggregate offering price of $2,876,601 pursuant to subscription agreements with accredited investors. The disclosure explicitly states the sale is exempt from Securities Act registration under Section 4(a)(2) and Regulation D Rule 506, which is the hallmark of a private placement. This is a material unregistered equity issuance that dilutes existing shareholders and represents a significant capital raise for the Fund.
View raw filing on EDGAR →Evolution Petroleum completed a registered public offering of 3,700,000 shares of common stock at $3.25 per share on August 20, 2026, with underwriters exercising their 30-day option for an additional 555,000 shares, generating net proceeds of approximately $12.4 million. This dilutive equity issuance raises capital for the company while diluting existing shareholders.
View raw filing on EDGAR →Edesa Biotech entered into an underwriting agreement on August 19, 2026 for a registered public offering of 3,870,500 common shares with warrants and 675,000 pre-funded warrants, raising approximately $25 million in gross proceeds ($23.1 million net). The offering includes an underwriter option for an additional 681,825 shares and represents a material dilutive equity issuance typical of clinical-stage biotech capital raises.
View raw filing on EDGAR →The 6-K discloses a private placement of 5,000,000 Class A ordinary shares at US$0.80 per share for aggregate gross proceeds of US$4,000,000, entered into on August 14, 2026. This is an unregistered equity issuance that dilutes existing shareholders and raises capital, fitting the definition of dilutive_issuance. The materiality is clear given the significant share count and capital raised.
View raw filing on EDGAR →This exhibit announces a registered direct offering of 1.75 million Class A Ordinary Shares at $1.00 per share, generating approximately $1.75 million in gross proceeds. The offering is structured as a registered direct offering under a Form F-3 shelf registration statement, which is a classic dilutive equity issuance. The announcement explicitly states the offering is expected to close on August 20, 2026, and involves institutional investors purchasing shares or pre-funded warrants, making this a material capital-raising event that would dilute existing shareholders.
View raw filing on EDGAR →QTREX announced pricing of a $10 million registered direct offering of 11,111,111 ordinary shares to institutional investors. This is a registered equity issuance under Form F-3 that will dilute existing shareholders. The announcement of definitive terms, pricing, and expected closing date (August 21, 2026) constitutes a material capital-raising event that would affect a reasonable investor's assessment of ownership dilution and the company's financing strategy.
View raw filing on EDGAR →AB Private Lending Fund completed an unregistered private placement of 40,519 Class I common shares of beneficial interest to feeder vehicles, exempt under Section 4(a)(2) and Regulation S, materially diluting existing shareholders.
View raw filing on EDGAR →Audax Private Credit Fund issued 1,718,450.952 limited liability company interests for $42.2 million on July 1, 2026, to accredited investors and non-U.S. persons pursuant to subscription agreements exempt from Securities Act registration under Section 4(a)(2) and Regulations D/S.
View raw filing on EDGAR →QNB Corp. completed a registered public offering of 1,232,142 shares of common stock at $42.00 per share (including the full exercise of the underwriters' 30-day overallotment option), generating approximately $48.3 million in net proceeds. The offering will be used for balance sheet restructuring, subordinated note redemption, and capital support, and materially dilutes existing shareholders' ownership and voting power.
View raw filing on EDGAR →Goldman Sachs Private Credit Corp. completed an unregistered sale of equity securities totaling approximately $155.7 million across Class I, S, and D shares pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions to accredited investors and non-U.S. persons.
View raw filing on EDGAR →EZGO Technologies entered into a securities purchase agreement on August 5, 2026, to issue 3,000,000 ordinary shares at US$0.50 per share for aggregate gross proceeds of US$1.5 million in a private investment in public equity (PIPE) transaction. The shares were issued on August 19, 2026, and were offered in reliance on Regulation S exemption from registration. This is a classic dilutive equity issuance that would materially affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →CleanCore Solutions disclosed a best efforts public offering of approximately 275.8 million shares of common stock, pre-funded warrants, and accompanying warrants to purchase 400 million additional shares. The filing confirms that as of August 20, 2026, the Company had 502.1 million shares outstanding as a result of this issuance. This represents a massive dilutive equity issuance that materially increases the share count and would significantly affect investor assessment of ownership dilution and earnings per share.
View raw filing on EDGAR →